New antibody reduces tumor growth in treatment-resistant breast, ovarian cancers: Study
London [UK], March 16 (ANI): Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventional treatments.
Tumours, such as some breast and ovarian cancers, can express the marker HER2.